The investigation of differences in albumin redox state between poorly and well-controlled DM patients within these groups in terms of a longitudinal prospective study would be especially interesting to investigate the impact of the different etiologies on the potential biomarkers HNA1 and HNA2. The gene discussed is CD177; the disease is diabetes mellitus.